IL18 and colitis: Researchers found that IL-18 mRNA and TNF-α mRNA levels were elevated in DSS-induced colitis, and the administration of pralnacasan significantly reduced the expression of IL-18 mRNA but did not affect the expression of TNF-α mRNA.